百龙创园：拟出资1000万元设立全资子公司

Core Viewpoint - The company plans to establish a wholly-owned subsidiary in Nanjing with an investment of 10 million RMB to enhance its international market presence and boost export revenue [1] Group 1 - The company will set up a subsidiary named Bailong Chuangyuan (Nanjing) Biotechnology Co., Ltd. with a registered capital of 10 million RMB [1] - The investment aims to strengthen the overseas sales team and actively explore international markets [1] - The initiative is expected to improve the company's export business income and overall profitability [1]